The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Molecular genetics of prostate cancer
Open accessAbstract
Prostate cancer afflicts one man in nine over the age of 65 and represents the most frequently diagnosed cancer in American men (Coffey 1993).Early detection through serum testing for prostate specific antigen (PSA) and improved procedures for surgical intervention and radiation therapy have significantly reduced the number of fatalities; however, there is still no effective cure for men with advanced disease.Therefore, much research has been dedicated to identifying prognostic markers that distinguish indolent versus aggressive forms of prostate cancer.In contrast, significantly less research has been devoted to understanding the molecular mechanisms that underlie normal prostate growth and development or cancer initiation and progression.In this review, we address recent progress toward the central objectives of understanding parameters of normal versus abnormal prostatic development and of elucidating a molecular pathway for prostate cancer progression.We focus on key regulatory molecules that have been implicated by analysis of patterns of allelic loss in human prostate cancers and/or by reverse genetic approaches in the mouse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–227 of 227
Trapman, J., Ris‐Stalpers, C., van der Korput, J. A. G. M., Kuiper, G. G. J. M., Faber, P. W., Romijn, J. C., Mulder, E., & Brinkmann, A. O. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90429-o · Cited by 68
Stem Cell Genes in Androgen-independent Prostate Cancer
BUI, M. H. T., & Reiter, R. E. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006197923640 · Cited by 67
Isolation of DICE1: A gene frequently affected by LOH and downregulated in lung carcinomas
Wieland, I., Arden, K. C., Michels, D., Klein‐Hitpaß, L., Böhm, M., Viars, C. S., & Weidle, U. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202806 · Cited by 67
Prendergast, N. J., Atkins, M. R., Schatte, E. C., Paulson, D. F., & Walther, P. J. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66165-2 · Cited by 66
Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development
Luukko, K., Ylikorkala, A., Tiainen, M., & Mäkelä, T. P. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00050-7 · Cited by 64
Immunohistochemical Detection of p53 Protein in Human Prostatic Cancer
Henke, R., Krüger, E., Ayhan, N., Hübner, D., Hammerer, P. G., & Huland, H. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32571-5 · Cited by 62
Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma
HALVORSEN, O. J., Hostmark, J. G., Haukaas, S. A., Høisaeter, P. A., & Akslen, L. A. (2000) · Cancer · Cited by 61
Androgen-receptor gene structure and function in prostate cancer
Hakimi, J. M., Rondinelli, R. H., Schoenberg, M., & Barrack, E. R. (1996) · World Journal of Urology · doi:10.1007/bf00184606 · Cited by 60
ANDROGEN RECEPTOR EXPRESSION IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND CANCER
SWEAT, S. D., Pacelli, A., Bergstralh, E. J., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61644-6 · Cited by 60
Overexpression of cyclin D1 is rare in human prostate carcinoma
Gumbiner, L. M., Gumerlock, P. H., Mack, P. C., Chi, S.-G., White, R. D., Mohler, J. L., Pretlow, T. G., & Tricoli, J. V. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990101)38:1<40::aid-pros5>3.0.co;2-i · Cited by 59
Identification of 12p as a region of frequent deletion in advanced prostate cancer.
Kibel, A. S., Schutte, M. E. M., Kern, S. E., Isaacs, W. B., & Bova, G. S. (1998) · PubMed · Cited by 58
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi, S. G., White, R. D., Muenzer, J. T., & Gumerlock, P. H. (1997) · PubMed · Cited by 53
p16 mutations/deletions are not frequent events in prostate cancer
Tamimi, Y., Bringuier, P., Smit, F. P., van Bokhoven, A., Debruyne, F. M. J., & Schalken, J. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.325 · Cited by 49
Kim, S. K., Ro, J. Y., Kemp, B. L., Lee, J. S., Kwon, T. J., Hong, W. K., & Mao, L. (1998) · Oncogene · doi:10.1038/sj.onc.1202073 · Cited by 48
Murray, H. E., & Gillies, G. E. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.00582.x · Cited by 47
Peptide Growth Factors and Prostate Cancer: New Models, New Opportunities
Foster, B. A., Kaplan, P. J., & Greenberg, N. M. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006162410436 · Cited by 45
Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer
Gu, K., Mes‐Masson, A., Gauthier, J. B., & Saad, F. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<164::aid-mc3>3.3.co;2-c · Cited by 45
Restriction of Neuroblastoma to the Prostate Gland In Transgenic Mice
Skalnik, D. G., Dorfman, D. M., Williams, D., & Orkin, S. H. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4518 · Cited by 41
Sarkar, F. H., Li, Y., Sakr, W., Grignon, D. J., Madan, S. S., Wood, D. P., & Adsay, V. N. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990901)40:4<256::aid-pros7>3.0.co;2-i · Cited by 41
Molecular Analysis of the INK4 Family of Genes in Prostate Carcinomas
Park, D. J., Wilczynski, S. P., Pham, E. Y., Miller, C. W., & Koeffler, H. P. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64917-6 · Cited by 35
Prostate specific expression of Cre recombinase in transgenic mice
Maddison, L. A., Nahm, H. S., DeMayo, F. J., & Greenberg, N. M. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2<154::aid-gene18>3.0.co;2-2 · Cited by 35
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk, M. A., Serth, J., Bokemeyer, C., Schwede, J., Herrmann, R., Machtens, S. A., Grünewald, V., Höfner, K., & Udo Jonas, A. (1998) · Oncology Reports · doi:10.3892/or.5.1.213 · Cited by 34
Absence of p16/MTS1 gene mutations in human prostate cancer
Chen, W., Weghorst, C. M., Sabourin, C. L. K., Wang, Y., Wang, D., Bostwick, D. G., & Stoner, G. D. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2603 · Cited by 34
Mutations of the p16 gene product are rare in prostate cancer
Gaddipati, J. P., McLeod, D. G., Sesterhenn, I. A., Hussussian, C. J., Tong, Y. A., Seth, P. K., Dracopoli, N. C., Moul, J. W., & Srivastava, S. K. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970215)30:3<188::aid-pros7>3.0.co;2-i · Cited by 29
p16 (CDKN2/MTS1) Gene Deletions are Rare in Prostatic Carcinomas in the United States and Japan
Mangold, K. A., Takahashi, H., Brandigi, C., Wada, T., Wakui, S., Furusato, M., Boyd, J. A., Chandler, F. W., & Allsbrook, W. C. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65152-8 · Cited by 18
Prognostic Markers in Localized Prostate Cancer: From Microscopes to Molecules
Harding, M. A., & Theodorescu, D. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006137721823 · Cited by 15
(1995) · PubMed
Cited by
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Metadata
- Authors
- Abate-Shen, C., & Shen, M. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-10-01
- Volume
- 14
- Issue
- 19
- Pages
- 2410-2434
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2064117760
- Cited by
- 735
- References
- 227
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.